Xconomy National

Archives

by in

Entry	Author	Date	Location
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets	Luke Timmerman	10/12/11	New York
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired	Luke Timmerman	05/23/11	National
The New Normal for Biotech Startups	James Posada	01/26/11	Seattle
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners	Ryan McBride	12/15/10	Boston
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan	Luke Timmerman	11/10/10	Seattle
La Jolla Pharmaceutical Revives With $6M Financing	Bruce V. Bigelow	05/26/10	San Diego
La Jolla Pharmaceutical: Going, Going, But Not Quite Gone	Denise Gellene	02/26/10	San Diego
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO	Luke Timmerman	01/07/10	Boston
Zymo Drug Fails Arthritis Trials	Luke Timmerman	09/10/09	Seattle
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News	Luke Timmerman	07/23/09	Seattle
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug	Luke Timmerman	07/21/09	Seattle
La Jolla Pharmaceutical Gets Delisting Notice	Juha-Pekka Tikka	04/09/09	San Diego
Biogen Idec, Extending Life of its Top-Selling Drug, Eyes Longer-Lasting Shot for MS	Luke Timmerman	03/27/09	Boston
Trubion Starts Lupus Trial	Luke Timmerman	03/25/09	Seattle
Biogen Idec, Genentech’s Rituxan Fails in Pivotal Study of Lupus of Kidneys	Luke Timmerman	03/11/09	Boston
Cypress Buys Lupus Test	Luke Timmerman	02/24/09	San Diego
La Jolla Pharmaceutical Looks at Sale or “Winding Down”	Bruce V. Bigelow	02/20/09	San Diego
La Jolla Pharmaceutical Stock Crashes After Drug Fails In Pivotal Clinical Trial	Luke Timmerman	02/12/09	San Diego
Sequenom Buys Small Diagnostic Maker	Luke Timmerman	01/26/09	San Diego
La Jolla Pharma Inks BioMarin Deal	Luke Timmerman	01/07/09	San Diego
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity	Luke Timmerman	12/17/08	Seattle
ZymoGenetics Drug For Hepatitis C Kills Virus with Minimal Side Effects	Luke Timmerman	11/03/08	Seattle
ZymoGenetics Drug Trial Halted Because of Infection Risk	Luke Timmerman	10/27/08	Seattle
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA	Luke Timmerman	09/03/08	Seattle
Novo Nordisk Returning to Seattle, Hiring 80 People by 2010	Luke Timmerman	08/05/08	Seattle
Page 1 of 1